Business Segment Information (Tables)

3 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Segment revenue

The following illustrates reportable and operating segment revenue for the periods indicated:

	Three months ended December 31,
(in thousands)	2019			2018
Pharmaceutical Distribution Services	$	46,036,828		$	43,744,381
Other:
MWI Animal Health	1,028,318			954,584
Global Commercialization Services	818,666			716,354
Total Other	1,846,984			1,670,938
Intersegment eliminations	(19,070		)	(22,867		)
Revenue	$	47,864,742		$	45,392,452

Segment operating income

The following illustrates reportable segment operating income for the periods indicated:

	Three months ended December 31,
(in thousands)	2019			2018
Pharmaceutical Distribution Services	$	391,694		$	373,207
Other	104,479			98,934
Intersegment eliminations	(907		)	(307		)
Total segment operating income	$	495,266		$	471,834

Reconciliation of total segment operating income to income (loss) from operations before income taxes

The following reconciles total segment operating income to income before income taxes for the periods indicated:

	Three months ended December 31,
(in thousands)	2019			2018
Total segment operating income	$	495,266		$	471,834
Gain from antitrust litigation settlements	8,492			87,279
LIFO (expense) credit	(13,281		)	3,029
PharMEDium remediation costs	(16,165		)	(20,495		)
New York State Opioid Stewardship Act	—			22,000
Acquisition-related intangibles amortization	(33,566		)	(45,152		)
Employee severance, litigation, and other	(39,309		)	(40,672		)
Impairment of long-lived assets	(138,000		)	—
Operating income	263,437			477,823
Other loss	2,842			3,097
Interest expense, net	31,007			42,170
Income before income taxes	$	229,588		$	432,556